Wellness Bio Radar
Latest clinical research, meta-analyses and scientific breakthroughs in health and longevity.
845 articles
A North American cross-sectional study published in September 2026 found that individuals with greater exposure to early life adversities had a higher likelihood of receiving a physician diagnosis of…
Janu Sirsasana, a seated forward bend, is a foundational yoga pose that targets the hamstrings and calves while promoting mental calm.
A retrospective analysis of over 20,000 patient records from Mass General Brigham, published September 24, 2026, reveals that cancer patients receiving immune checkpoint inhibitors who also require…
Researchers at the Terasaki Institute for Biomedical Innovation have unveiled a new wearable device.
Researchers have demonstrated that a single administration of psilocybin significantly enhances social behavior in mice carrying genetic markers associated with autism spectrum disorder. This…
A Swedish study tracking 3.7 million people found that rare TORCH infections transmitted from mother to fetus raise autism risk by about threefold and increase intellectual disability risk. The…
Researchers followed 887 children with high genetic risk for type 1 diabetes from birth through early childhood, tracking changes in their gut bacteria. The study, conducted across multiple sites in…
A recent study published in Nature Neuroscience suggests that functional magnetic resonance imaging (fMRI), the primary tool for mapping brain activity, may frequently produce inaccurate readings of…
Researchers have discovered a completely new feature in brains affected by Alzheimer's disease, involving clustered and damaged cellular power plants packed tightly inside nerve fibers. Published in…
Researchers have confirmed that consuming high amounts of ultra-processed foods significantly increases the likelihood of developing serious chronic conditions. This finding comes from a…
Researchers reported significant findings in endocrinology regarding bone health interventions. A recent study highlighted that one stem cell infusion could lower the rate of fragility fractures by…
A Phase 1b study released this week found that ALKS 7290, an investigational orexin‑2 agonist, markedly reduced symptoms of attention‑deficit/hyperactivity disorder in adults. The double‑blind,…